More Articles Back to Article
Japan approves Myriad's BRACAnalysis diagnostic system
Myriad Genetics has obtained approval from Japan's Ministry of Health, Labor and Welfare for its BRACAnalysis Diagnostic System, which is designed to identify breast cancer patients with germline mutations of BRCA1 and BRCA2. Patients may be recommended for prophylactic surgeries when tested positive for the said mutations. 360Dx (tiered subscription model) (11/21)
Read full article now.
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!